Remus Pharmaceuticals Financial Analysis
REMUS • Healthcare — current price unavailable, intrinsic value cannot be calculated. Financial fundamentals available below.
REMUS Cash Flow Quality — Operating & Free Cash Flow
Remus Pharmaceuticals operating cash flow, free cash flow, quality rating and sustainability score — key DCF inputs available despite missing price data.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹7 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹1 Cr | ₹-12 Cr | Positive Operating Cash Flow | 6/10 |
REMUS Intrinsic Value — Price Data Required for DCF & Graham Number
Why is intrinsic value important?
Intrinsic value represents the true worth of a company based on its fundamentals, independent of market sentiment. It helps investors identify:
- Whether a stock is overvalued or undervalued
- Long-term investment opportunities
- Fair value ranges for entry and exit points
What happens when price data is unavailable?
While we cannot calculate intrinsic value without current market price, you can still assess the company's financial health using metrics like ROE, debt ratios, profitability margins, and cash flow quality shown above.
REMUS Financial Health — Ratios, Margins & Debt Analysis
Remus Pharmaceuticals profitability, liquidity and leverage ratios with ratings and interpretation — available without current price data.
| Metric | Value | Rating | Interpretation |
|---|---|---|---|
Related Analysis
- For current market price and key ratios, visit REMUS stock live price.
- Browse Remus Pharmaceuticals financial data for revenue, profit, balance sheet and cash flow data.
- Compare with REMUS fair value to assess whether the stock is under or overvalued.